Pages that link to "Q27682197"

The following pages link to The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions (Q27682197):

Displaying 25 items.

• LipidII: Just Another Brick in the Wall? (Q26775024) (← links)
• Distinct mechanisms contribute to immunity in the lantibiotic NAI-107 producer strain Microbispora ATCC PTA-5024 (Q27700284) (← links)
• A relA-dependent regulatory cascade for auto-induction of microbisporicin production in Microbispora corallina (Q28831361) (← links)
• Depletion of Undecaprenyl Pyrophosphate Phosphatases Disrupts Cell Envelope Biogenesis in Bacillus subtilis. (Q30819563) (← links)
• The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa. (Q34167642) (← links)
• In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model (Q35105932) (← links)
• Elucidating the molecular physiology of lantibiotic NAI-107 production in Microbispora ATCC-PTA-5024. (Q35891264) (← links)
• Structure and tRNA Specificity of MibB, a Lantibiotic Dehydratase from Actinobacteria Involved in NAI-107 Biosynthesis (Q36703347) (← links)
• The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300. (Q37203727) (← links)
• Growing the seeds sown by Piero Sensi (Q38239458) (← links)
• Advancing cell wall inhibitors towards clinical applications (Q38620000) (← links)
• Targeting bactoprenol-coupled cell envelope precursors (Q38919751) (← links)
• Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies (Q39065285) (← links)
• Macromolecule Biosynthesis Assay and Fluorescence Spectroscopy Methods to Explore Antimicrobial Peptide Mode(s) of Action (Q39066115) (← links)
• Targeting a cell wall biosynthesis hot spot (Q39413308) (← links)
• VraH Is the Third Component of the Staphylococcus aureus VraDEH System Involved in Gallidermin and Daptomycin Resistance and Pathogenicity (Q39516895) (← links)
• Extraction and Analysis of Peptidoglycan Cell Wall Precursors. (Q39677717) (← links)
• LsbB Bacteriocin Interacts with the Third Transmembrane Domain of the YvjB Receptor (Q41717546) (← links)
• Ribosomal Natural Products, Tailored To Fit. (Q47953416) (← links)
• Two Flavoenzymes Catalyze the Post-Translational Generation of 5-Chlorotryptophan and 2-Aminovinyl-Cysteine during NAI-107 Biosynthesis (Q48108610) (← links)
• Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells (Q50221694) (← links)
• Determination of Structure and Micellar Interactions of Small Antimicrobial Peptides by Solution-State NMR. (Q51237257) (← links)
• Antibakterielle Strategien und bakterielle Abwehrmechanismen (Q58915914) (← links)
• An engineered double lipid II binding motifs-containing lantibiotic displays potent and selective antimicrobial activity against E. faecium (Q90369645) (← links)
• More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin (Q92703232) (← links)